Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/04/1998CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen
11/04/1998CN1198090A Use of autologous dermal fibroblasts for repair of skin and soft tissue defects
11/04/1998CN1040541C Preparation of polypeptide compound
11/03/1998US5831141 Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter
11/03/1998US5831094 Difluoro statone antiviral analogs
11/03/1998US5831074 Eucaryotic NAD cyclases
11/03/1998US5831071 Using anhydrous solution of triethylamnine-hydrogen fluoride
11/03/1998US5831069 Genetic engineering; hybrids
11/03/1998US5831067 Nucleotide sequence with complimentary sequence to a domain of mrna of tumor suppressor retinoblastoma or p16 genes
11/03/1998US5831066 B-CELL LYMPHOMA/LEUKEMIA GENE (bcl-2); ANTISENSE AGENT COMPRISING A SYNTHETIC 18 BASE PHOSPHOROTHIOATE OLIGONUCLEOTIDE; ANTICANCER AGENT, OBLIMERSEN; ANTICANCER AGENT; SENSITIZING TUMOR CELLS TO CHEMOTHERAPY
11/03/1998US5831063 Monoclonal antibodies
11/03/1998US5831058 Human GDP dissociation stimulating protein gene
11/03/1998US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998US5831054 Polynucleotide encoding growth differentiation factor-12
11/03/1998US5831052 New human translocation associated protein
11/03/1998US5831049 Polynucleotide sequence
11/03/1998US5831048 Grb3-3 cDNA and polypeptides
11/03/1998US5831033 Human thymosin β15 gene, protein and uses thereof
11/03/1998US5831031 Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
11/03/1998US5831030 Antibodies specific for megakaryocyte differentiation factor
11/03/1998US5831029 Human β2 integrin α subunit
11/03/1998US5831027 Heat treated, lyophilized fibrinogen
11/03/1998US5831026 Process for purifying factor VIII
11/03/1998US5831025 Human activated protein C and process for preparing same
11/03/1998US5831023 Recombinant animal interferon polypeptides
11/03/1998US5831022 Interleukins
11/03/1998US5831018 Human cytochrome B5
11/03/1998US5831017 Divalent metal complex
11/03/1998US5831016 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
11/03/1998US5831015 Colon mucosa gene having down-regulated expression in colon adenumas and adenocarcinomas
11/03/1998US5831013 Capsid polypeptides and use to inhibit viral packaging
11/03/1998US5831009 Protein phosphotyrosine phosphatases PTP-D1
11/03/1998US5831008 Retinoblastoma protein-interacting zinc finger proteins
11/03/1998US5831007 Proteins
11/03/1998US5831005 Synthesis of N-substituted oligomers
11/03/1998US5831002 Hybrid polypeptide
11/03/1998US5831001 Treatment of herpesvirus infection
11/03/1998US5831000 Hybrid calcitonin
11/03/1998US5830999 Carboxylic ligands, hexamers
11/03/1998US5830998 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
11/03/1998US5830996 Cyclic peptide antitumor agent from an ascidian
11/03/1998US5830995 Fanphiregulins: a family of heparin-binding epithelial cell growth factors
11/03/1998US5830994 Peptide derivatives of alpha-MSH and their application
11/03/1998US5830993 Polypeptide
11/03/1998US5830898 Enantiomerically pure β-di-dioxolane-nucleosides with selective anti-hepatitis B virus activity
11/03/1998US5830897 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/03/1998US5830887 Cancer, pms, menopause and hypercholesterolemia
11/03/1998US5830882 Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830879 Gene transfer therapy
11/03/1998US5830878 1,2-bis(2-oleoyloxy)ethyl)-3-(2-hydroxyethyl)imidazolinium chloride
11/03/1998US5830877 Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
11/03/1998US5830874 Compositions and methods for the treatment of arterial chlamydial granuloma
11/03/1998US5830870 Prevent loss of muscle mass
11/03/1998US5830869 Metalloprotease inhibitor
11/03/1998US5830868 Substituted DI- and tripeptide inhibitors of protein: farnesyl transferase
11/03/1998US5830867 Hemoregulatory peptides for stimulating the myelopoietic system
11/03/1998US5830866 Corticotropin release inhibiting factor and methods of using same
11/03/1998US5830865 Modified tripeptide stabilizer
11/03/1998US5830864 Antiherpes peptide derivatives having a ureido n-terminus
11/03/1998US5830863 Naturally occurring neurokinin a with modified amide bond connecting the two amino acids on the carboxy terminal
11/03/1998US5830860 Peptides with bactericidal activity and endotoxin neutralizing activity for gram negative bacteria and methods for their use
11/03/1998US5830858 Neurotrophic factor
11/03/1998US5830857 Using polypeptide
11/03/1998US5830855 Lipodepsipeptides as antifungal and fungicidal agents
11/03/1998US5830854 Method of treating cystic fibrosis using a tachykinin receptor antagonist
11/03/1998US5830853 Administering insulin and absorption enhancer using a dry powder inhaler
11/03/1998US5830851 Methods of administering peptides that bind to the erythropoietin receptor
11/03/1998US5830849 Vampire bat salivary plasminogen activators
11/03/1998US5830848 Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy
11/03/1998US5830847 Soluble TGF-β-binding endoglin polypeptides and homodimers
11/03/1998US5830759 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/03/1998US5830758 Binding to lymphocytes
11/03/1998US5830756 DNA and expression vector encoding IκB Protein
11/03/1998US5830755 T-cell receptors and their use in therapeutic and diagnostic methods
11/03/1998US5830754 Recombinant DNA-produced T11 and fragments thereof
11/03/1998US5830753 Isolated nucleic acid molecules coding for tumor rejection antigen precursor dage and uses thereof.
11/03/1998US5830751 Yeast cells
11/03/1998US5830747 Plant arabinogalactan protein (AGP) genes
11/03/1998US5830739 Extracting bromelain with ascorbic acid
11/03/1998US5830731 Insertion dna segments into cloning vectors
11/03/1998US5830721 Libraries of peptides, antibodies
11/03/1998US5830715 Releasing trehalose from nonreducing saccharides
11/03/1998US5830710 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
11/03/1998US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998US5830703 DNA encoding adrenomedullin
11/03/1998US5830700 Hybrid proteins having cross-linking and tissue-binding activities
11/03/1998US5830699 SOK-1 and methods of use
11/03/1998US5830697 P-glycoprotein mutant resistant to cyclosporin modulation
11/03/1998US5830686 Gene expression
11/03/1998US5830684 Production of native or recombinant guanine triphosphatase-activating protein
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998US5830670 Definitive diagnostic test
11/03/1998US5830667 Human P450 IID6 cytochrome-derived peptide fragments, anti-peptide fragment antibodies, applications thereof in the diagnosis of autoimmune hepatitis
11/03/1998US5830660 Tumorigenesis protein
11/03/1998US5830650 Walk-through mutagenesis
11/03/1998US5830647 Hybridization and amplification of nucleic acids encoding mpl ligand
11/03/1998US5830644 Method for screening for agents which increase telomerase activity in a cell
11/03/1998US5830641 Nucleotide sequence used as hybrid probe
11/03/1998US5830640 Analyzing for uteroglobin protein in cells
1 ... 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 ... 3163